Boditech Med Inc. (KOSDAQ:A206640) announces a share repurchase program. Under the program, the company will repurchase KRW 5,000 million under the contract with Daishin Securities Co., Ltd. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will be valid until June 13, 2022.

As of December 13, 2021, the company had 728,573 shares in treasury under the dividend capacity and no shares in treasury under other capacities.